What is pathophysiology of Prostate cancer?

Teerera peji iri

Chii chinonzi pathophysiology yekenza yeprostate?

Pathophysiology yekenza yeprostate inoreva mashandiro epasi uye maitiro anotungamira mukusimudzira uye kufambira mberi kwechirwere.

Kenza yeprostate igomarara rakaipa rinobva mumasero eprostate gland, inova nhengo duku ine chimiro chewalnut iri pasi pechiropa chevarume.

Prostate gland inogadzira mvura yembeu, iyo inodyisa uye inotakura mhodzi.

Chikonzero chaicho chokenza yeprostate hachina kunyatsonzwisiswa, asi zvinhu zvinoverengeka zvinozivikanwa kuti zvinowedzera ngozi yokuva nechirwere ichi.

Izvi zvinosanganisira zera, nhoroondo yemhuri, dzinza, uye zvimwe zvinhu zvinoshanduka-shanduka.

Kenza yeprostate inowanzoitika muvarume vakwegura, uye vakawanda vacho vane makore anopfuura 65.

Mukuwedzera, varume vane nhoroondo yemhuri yekenza yeprostate vari panjodzi yakawedzera, sezvakaita varume vokuAfrica vokuAmerica nevarume vanobva kuCaribbean.

Pathophysiology yekenza yeprostate inobatanidza kukura kusingadzorwi uye kupatsanurwa kwemasero mukati meprostate gland.

Ikoku kunogona kuitika nemhaka yokushanduka-shanduka kwedzinza kunotungamirira kukuratidzwa kwakanyanyisa kwezvimwe zvinhu zvinokonzera kukura kana kuti kusashanda kwemagene anodzvinyirira bundu.

Shanduko idzi dzinogona kuita kuti masero awedzere kukura zvisina kurongwa, zvichiita kuti pave netumor.

Sezvo bundu racho rinokura, rinogona kupinda mumatumbu nemitezo iri pedyo, zvakadai sechiropa, rectum, uye lymph nodes dziri pedyo.

Mune zvimwe zviitiko, masero ekenza anogona kuparadzana netumor yokutanga ndokupararira kune dzimwe nzvimbo dzomuviri kupfurikidza neropa kana kuti lymphatic system, muitiro unozivikanwa se metastasis.

Kamwe kenza yapararira, inogona kuva yakaoma zvikuru kurapa.

Kenza yeprostate inogonawo kukanganiswa nezvinhu zvinokonzerwa nehormone, zvikurukuru androgen hormone testosterone.

Testosterone inogona kukurudzira kukura kwemasero ekenza yeprostate, uye kurapwa kwakawanda kwekenza yeprostate kunovavarira kuderedza mwero weiyi hormone kana kuvhara migumisiro yayo.

Muchidimbu, pathophysiology yekenza yeprostate inobatanidza kukura kusingadzorwi uye kupatsanurwa kwemasero mukati meprostate gland, izvo zvinogona kukanganiswa nezvinhu zvedzinza, zvehomoni, uye zvemhoteredzo.

Kunzwisisa mashandiro anoita chirwere ichi kunokosha pakugadzira mishonga inoshanda uye kuvandudza marapirwo anoitwa varwere vane kenza yeprostate.

Mashoko okufananidzira

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Zobniw CM, Causebrook A, Fong MK: Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer. Res Rep Urol. 2014, 6 (): 97-105.

Lim HY, Agarwal AM, Agarwal N, Ward JH: Recurrent epistaxis as a presenting sign of androgen-sensitive metastatic prostate cancer. Singapore Med J. 2009, 50 (5): e178-80.

Kohli M, Qin R, Jimenez R, Dehm SM: Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer. Adv Urol. 2012, 2012 (): 781459.

Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW: Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med. 1995, 1 (9): 944-9.

Msaouel P, Nandikolla G, Pneumaticos SG, Koutsilieris M: Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer. Expert Opin Investig Drugs. 2013, 22 (11): 1385-400.

Kotani K, Sekine Y, Ishikawa S, Ikpot IZ, Suzuki K, Remaley AT: High-density lipoprotein and prostate cancer: an overview. J Epidemiol. 2013, 23 (5): 313-9.

Jadvar H: Molecular imaging of prostate cancer: a concise synopsis. Mol Imaging. , 8 (2): 56-64.

Kurambidzwa kwebasa: zvokurapa

Nzvimbo iyi yepaIndaneti inopiwa nokuda kwezvinangwa zvedzidzo uye zvemashoko chete uye haisi kupa mazano ezvokurapa kana kuti mabasa ehunyanzvi.

Mashoko anopiwa haafaniri kushandiswa kuongorora kana kuti kurapa chinetso cheutano kana kuti chirwere, uye avo vanotsvaka mazano ezvokurapa vanofanira kubvunza chiremba ane rezinesi.

Ndapota cherechedzai kuti neural net iyo inogadzira mhinduro dzemibvunzo, haina kururama zvikuru kana iri nyaya yenhamba. Somuenzaniso, nhamba yevanhu vanoonekwa vaine chirwere chakati.

Nguva dzose tsvaka zano rachiremba wako kana mumwe mupi wezvoutano akakodzera pamusoro pemamiriro ezvinhu ezvokurapa. Usambofa wakaregeredza zano rezvokurapa rehunyanzvi kana kunonoka kuritsvaka nemhaka yechinhu chipi nechipi chawakaverenga pawebsite ino. Kana uchifunga kuti unogona kuva nenjodzi yezvokurapa, fonera 911 kana kuenda kukamuri rokukurumidzira riri pedyo nokukurumidza. Hapana ukama hwechiremba nemurwere hunogadzirwa newebhusaiti ino kana kushandiswa kwayo. NeBioMedLib kana vashandi vayo, kana chero mupiro kune iyi webhusaiti, haitauri chero zvirevo, zvakataurwa kana kuti zvataurwa, maererano neruzivo rwunopihwa pano kana kushandiswa kwayo.

Kurega mutoro: kodzero dzekunyora

Digital Millennium Copyright Act ya1998, 17 U.S.C. § 512 (iyo DMCA) inopa nzira yekutsvaga varidzi vemvumo vanotenda kuti zvinhu zvinoonekwa paInternet zvinotyora kodzero dzavo pasi pemutemo wekodzero dzeUS.

Kana iwe uchidavira mukutenda kwakanaka kuti chero zvemukati kana zvinhu zvakaitwa kuti zviwanikwe zvine chekuita newebhusaiti yedu kana masevhisi zvinotyora kodzero dzako, iwe (kana mumiririri wako) unogona kutitumira chiziviso chinokumbira kuti zvemukati kana zvinhu zvibviswe, kana kuwana kwazviri kuvharirwa.

Zviziviso zvinofanira kutumirwa zvakanyorwa neemail (ona chikamu che"Kubata" kuti uwane kero yeemail).

DMCA inoda kuti chiziviso chako chekutyora kwekodzero dzekodzero dzekodzero zvinosanganisira ruzivo runotevera: (1) tsananguro yebasa rine kodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero.

(5) chirevo chako, chakasainwa pasi pechirango chehupombwe, chokuti mashoko ari mukuziviswa ndeechokwadi uye kuti une simba rokumanikidza kodzero dzevanyori dzinonzi dzakaputsika;

uye (6) siginicha yepanyama kana yemagetsi yemuridzi wekodzero kana munhu ane mvumo yekuita muzita remuridzi wekodzero.

Kukundikana kuisa mashoko ose ari pamusoro apa kungaguma nokunonoka kugadziriswa kwekunyunyuta kwako.

Kutaurirana

Ndapota titumirei email nemibvunzo ipi neipi / mazano.

What is pathophysiology of prostate cancer?

The pathophysiology of prostate cancer refers to the underlying mechanisms and processes that lead to the development and progression of the disease.

Prostate cancer is a malignant tumor that arises from the cells of the prostate gland, which is a small, walnut-shaped organ located below the bladder in men.

The prostate gland produces seminal fluid, which nourishes and transports sperm.

The exact cause of prostate cancer is not fully understood, but several factors are known to increase the risk of developing the disease.

These include age, family history, race, and certain genetic mutations.

Prostate cancer is more common in older men, with the majority of cases occurring in men over the age of 65.

Additionally, men with a family history of prostate cancer are at an increased risk, as are African American men and men of Caribbean descent.

The pathophysiology of prostate cancer involves the uncontrolled growth and division of cells within the prostate gland.

This can occur due to genetic mutations that lead to the overexpression of certain growth factors or the inactivation of tumor suppressor genes.

These mutations can result in the unregulated growth of cells, leading to the formation of a tumor.

As the tumor grows, it can invade nearby tissues and organs, such as the bladder, rectum, and nearby lymph nodes.

In some cases, cancer cells can break away from the primary tumor and spread to other parts of the body through the bloodstream or lymphatic system, a process known as metastasis.

Once the cancer has spread, it can be more difficult to treat.

Prostate cancer can also be influenced by hormonal factors, particularly the androgen hormone testosterone.

Testosterone can stimulate the growth of prostate cancer cells, and many treatments for prostate cancer aim to reduce the levels of this hormone or block its effects.

In summary, the pathophysiology of prostate cancer involves the uncontrolled growth and division of cells within the prostate gland, which can be influenced by genetic, hormonal, and environmental factors.

Understanding the underlying mechanisms of the disease is crucial for developing effective treatments and improving outcomes for patients with prostate cancer.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.